期刊文献+

我院重症感染新生儿应用万古霉素血药浓度监测结果分析 被引量:11

Result Analysis of Plasma Concentration Monitoring of Vancomycin in Neonate with Severe Infection in Our Hospital
原文传递
导出
摘要 目的:为促进重症感染新生儿合理应用万古霉素提供参考。方法:回顾性分析我院2012年6月-2014年6月间重症感染新生儿的万古霉素血药浓度监测结果及其相关信息。结果:30例重症感染新生儿应用万古霉素治疗总有效率为63.33%。其中,7例稳态谷浓度小于10 mg/L(占23.33%),有效率为16.67%;22例在10~20 mg/L(占73.33%),有效率为77.27%;1例大于20 mg/L(占3.33%),有效率为100%。有2例采用qd给药,疗程最短的仅2 d。病原学检查送检率为96.67%,其中阳性率为89.65%。治疗期间未发现患儿有明显不良反应及肝、肾功能损害情况。结论:我院重症感染新生儿应用万古霉素治疗总有效率偏低,可能与万古霉素的稳态谷浓度偏低有关。部分临床应用尚不够规范,存在疗程不足、给药间隔不当等不合理用药情况。严格按标准使用及加强血药浓度监测对指导万古霉素临床合理应用具有重要意义。 OBJECTIVE:To provide reference for promoting the rational use of vancomycin in neonate with severe infection.METHODS:The results of plasma concentration monitoring of neonate with severe infection in our hospital from Jun.2012 to Jun.2014 and related information were retrospectively analyzed.RESULTS:The total effective rate of vancomycin in 30 neonates with severe infection was 63.33%.Among these,7 cases(23.33%)were less than 10 mg/L with an effective rate of 16.67%;22 cases(73.33%)were in the range of 10-20 mg/L with an effective rate of 77.27%;1 case(3.33%)was more than 20 mg/L with an effective rate of 100%.2 cases were administrated,qd,and the shortest course was only 2 d.96.67% received etiological examination and 89.65% showed positive.There were no obvious adverse reactions and the damage of liver and kidney function.CONCLUSIONS:The low effective rate of vancomycin in neonate with severe infection in our hospital may be related to the low steady-state plasma concentration.Part of the clinical application is still non-standard,such as not enough course and improper dosing interval,etc.Strengthening the supervision of application standard and the monitoring of plasma concentration has important significance for rational use of drug.
出处 《中国药房》 CAS 北大核心 2015年第15期2041-2043,共3页 China Pharmacy
关键词 万古霉素 重症感染 新生儿 血药浓度 监测 Vancomycin Severe infection Neonate Plasma concentration Monitoring
  • 相关文献

参考文献10

  • 1张晓,游楚明,傅万海,林茂锐,李惠怡.新生儿败血症病原学及耐药性分析[J].河北医药,2013,35(11):1722-1723. 被引量:6
  • 2Khotaei GT, Jam S, SeyedAlinaghi S, et al. Monitoring of serum vancomycin concentrations in pediatric patients with normal renal function[J]. Original Report Acta Medi- ca Iranica, 2010, 48(2) : 92.
  • 3孙浩,徐英宏,刘晓东,菅凌燕,肇丽梅,王大南,臧彬.万古霉素血清药物浓度监测及临床应用分析[J].实用药物与临床,2013,16(6):521-524. 被引量:12
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:37-39.
  • 5张华年.儿童万古霉素治疗药物监测及给药方案研究进展[J].儿科药学杂志,2014,20(5):55-58. 被引量:1
  • 6万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561-573. 被引量:608
  • 7Rybak M J, Lomaestro BM, Rotschafer JC, et al. Thera- peutic monitoring of vancomycin in adult patients: a con- sensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists[J]. Am JHealth Syst Pharm, 2009, 66( 1 ) : 82.
  • 8Myrvang H.Dialysis. cefazolin associated with better out- comes than is vancomycin for MSSA infection[J]. Nat Rev Nephrol, 2012,8(10) : 556.
  • 9Plan O, Cambonie G, Barbotte E, et al. Continuous-infu- sion vancomycin therapy for preterm neonates with sus- pected or documented Gram-positive infections: a new dosage schedule[J]. Arch Dis ChiM Fetal Neonatal Ed, 2008,93(6) :418.
  • 10Gwee A, Cranswick N, Metz D, et al. Neonatal vanco- mycin-continuous-infusion still a confusion? [J]. The Pedi- atric Infectious Disease Journal, 2014,33 (6) : 600.

二级参考文献30

  • 1叶晓涛,郑望春,黄衍锋,张旭.新生儿败血症病原菌及药物敏感性[J].检验医学与临床,2007,4(3):166-168. 被引量:12
  • 2Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeuticmonitoring of vancomycin in adults summary of consensus rec- ommendations from the American Society of Health-System Pharmacists,the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists [J] Pharmaco- therapy ,2009,29 ( 11 ) : 1275-1279.
  • 3Myrvang H. Dialysis:cefazolin associated with better outcomes than is vancomycin for MSSA infection [J]. Nat Rev Nephrol, 2012,8 (10) :556.
  • 4Pal MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients [ J ]. Pharrnacotherapy, 2007,27 ( 8 ) : 1081- 1091.
  • 5Kollef MH. Limitations of vancomycin in the management ofresistant staphylococcal infections[J]. Clin Infect Dis ,2007, 45(3) :S191-195.
  • 6Aubron C, Corallo CE, Nunn MO, et al. Evaluation of the Ac- curacy of a Pharmacokinetic Dosing Programin Predicting Ser- um Vancomycin Concentrations in Critically Ill Patients [J] Ann Pharmacother,2011,45 ( 10 ) : 1193-1198.
  • 7V6zquez M, Fagiolino P, Boronat A, et al. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock [ J ]. Int J C lin Pharmacol Ther, 2008,46 ( 3 ) : 140-145.
  • 8Vandecasteele S J, De Bacquer D, De Vriese AS. Implementa- tion of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing he- modialysis [J]. Clin Infect Dis, 2011,53 ( 2 ) : 124 -129.
  • 9Thomson AH, Staatz CE, Tobin CM, et al. Development and evaluation of vancomycin dosage guidelines designed to a- chieve new target concentrations [ J ]. J Antimicrob Chemoth- er,2009,63 ( 5 ) : 1050-1057.
  • 10Brown M, Polisetty R, Gracely El, et al. Weight-Based Load- ing of Vancomycin in Patients onHemodialysis [J]. Clin Infect Dis,2011,53(2) :164-166.

共引文献623

同被引文献78

  • 1抗菌药物临床应用指导原则[J].中国中医药现代远程教育,2005,3(2):13-15. 被引量:5
  • 2孙红,陈莎,段艺,艾洪武,胡红兵,游上游.血清胱抑素C在儿童肾脏疾病中的应用研究[J].微循环学杂志,2005,15(4):31-32. 被引量:40
  • 3卢岩,孙健,张静,谈恒山.340例万古霉素血药浓度监测及临床用药合理性分析[J].中国医院药学杂志,2007,27(5):649-651. 被引量:38
  • 4徐进,许静,李燕,赵幽燕,谭家风,徐英美,赵真龄.新生儿的万古霉素血药浓度监测及安全性评价[J].中国医院药学杂志,2007,27(9):1200-1203. 被引量:13
  • 5RYBAK M,LOMAESTRO B,ROTSCHAFER JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst Pharm,2009,66(1):82-92.
  • 6TANAKA A,SUEMARU K,OTSUKA T,et al.Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function[J].Ther Drug Monit,2007,29(2):261-264.
  • 7FRYMOYER A,HERSH AL,BENET LZ,et al.Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate[J].Pediatr Infect Dis J,2009,28(5):398-402.
  • 8HAZLEWOOD KA,BROUSE SD,PITCHER WD,et al.Vancomycinassociated nephrotoxicity:grave concern or death by character assassination?[J].Am J Med,2010,123(2):182.
  • 9MEIER P,FROIDEVAUX C,DAYER E,et al.Cystatin C concentration and glomerular filtration rate[J].Lancet,2001,357(9256):634-635.
  • 10COLL E,BOTEY A,ALVAREZ L,et al.Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J].Am J Kidney Dis,2000,36(1):29-34.

引证文献11

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部